A study of specimens from 80 melanoma patients showed that FKBP51 was expressed in all cutaneous malignant melanomas analyzed but not in normal skin; expression was higher in melanocytes during the vertical growth phase compared to the radial growth phase and correlated with the thickness of the tumor lesion. Here, FKBP4 is linked to neoplasm.